1. Ability to use a mobile device or computer with broadband internet access (or data streaming available)

2. Ability to read, understand, and respond in English

3. Adult aged 18 years of age or over at the time of the survey

4. Self-confirmed diagnosis of MS

5. Prescribed either OMB or OCR SC and will receive their first injection (Day 0) followed by completing the study survey between Day 1 and Day 7

Multiple Sclerosis Patient Experience on Kesimpta and Ocrevus Subcutaneous Formulation